Document is current
Any future updates will be listed below
-
Authors
Martin, Laetitia B. B. https://orcid.org/0000-0002-6921-7246
Kikuchi, Shingo https://orcid.org/0000-0001-9033-6242
Rejzek, Martin https://orcid.org/0000-0002-5091-544X
Owen, Charlotte https://orcid.org/0000-0001-9023-2179
Reed, James https://orcid.org/0000-0001-5780-6134
Orme, Anastasia
Misra, Rajesh C. https://orcid.org/0000-0001-9594-3789
El-Demerdash, Amr https://orcid.org/0000-0001-6459-2955
Hill, Lionel
Hodgson, Hannah https://orcid.org/0000-0002-9499-7037
Liu, Yuzhong
Keasling, Jay D.
Field, Robert A. https://orcid.org/0000-0001-8574-0275
Truman, Andrew W. https://orcid.org/0000-0001-5453-7485
Osbourn, Anne https://orcid.org/0000-0003-2195-5810
-
Funding
Funding for this research was provided by:
RCUK | Biotechnology and Biological Sciences Research Council (BB/R005508/1, BBS/E/J/000PR9790, BB/R005508/1, BB/R005508/1, BBS/E/J/000PR9790, BBS/E/J/000PR9790, BB/R005508/1, BB/R005508/1, BB/R005508/1, BBS/E/J/000PR9790, BBS/E/J/000PR9790)
- License Information
-
More Information
Article History
Received: 11 March 2023
Accepted: 20 December 2023
First Online: 26 January 2024
Competing interests
: J.R., A. Orme, L.B.B.M., C.O. and A. Osbourn are inventors of patents arising from this work (WO2023/180677, pending application). J.D.K. has financial interests in Amyris, Ansa Biotechnologies, Apertor Pharma, Berkeley Yeast, Cyklos Materials, Demetrix, Lygos, Napigen, ResVita Bio and Zero Acre Farms. The remaining authors declare no competing interests.
